Clinical Trial Update: Aneurysm Study of Pipeline in an Observational Registry

View source ↗

Summary

An observational registry study evaluating the Pipeline Embolization Device for cerebral aneurysm has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Aneurysm

Drugs mentioned

• Pipeline Embolization Device (Flow-diverting stent)

Snippet

Sponsor: Medtronic Neurovascular Clinical Affairs | Conditions: Brain Aneurysm | Status: TERMINATED